BISOPROLOL fumarate, 5mg, tab.
NST
DORABISO5T-
Valid Article
HS Code:
300490
Last Updated on:
07/11/2024, 18:34:10
Former
Code(s):
DORAZNL0315 DORAZBD0374 DORABISO5T
12.1 - Antianginal medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
12.2 - Antiarrhythmic medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
12.3 - Antihypertensive medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
12.4 - Medicines used in heart failure
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
C07AB07
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
BISOPROLOL
Therapeutic Action
Cardioselective beta-blocker
Indications
Hypertension and chronic stable angina pectoris
Stable chronic heart failure in combination with a converting enzyme inhibitor (enalapril)
Instructions for use
To be taken in morning with or without food. Do not chew.
Bisoprolol replaces atenolol.
The 10 mg tablets (quadrisected tablets) replace the 5 mg tablets.
Precautions for Use
Contraindicated in asthmatic patients.
Storage
Below 25ºC